Stress News and Research

RSS

Dieting in pregnancy can be beneficial and reduce complications

For pregnant women, including those who are overweight and obese, following a healthy calorie controlled diet during pregnancy is safe and can reduce the risk of serious complications such as pre-eclampsia, diabetes and premature birth, finds a study published on bmj.com.

21 May 2012

Pernix Therapeutics introduces Omeclamox-Pak® for the treatment of H. pylori infection and duodenal ulcer disease

Pernix Therapeutics Holdings, Inc. (NYSE Amex: PTX), a specialty pharmaceutical company, today announced the introduction of Omeclamox-Pak®, a ten-day therapy of omeprazole delayed-release capsules (20 mg), clarithromycin tablets (500 mg) and amoxicillin capsules (500 mg) for the treatment of Helicobacter pylori (H. pylori) infection and duodenal ulcer disease (active or one-year history) to eradicate H. pylori in adult patients.

21 May 2012

Auranofin effective against amoebas in lab and animal studies

A team of researchers from UCSF and UC San Diego has identified an approved arthritis drug that is effective against amoebas in lab and animal studies, suggesting it could offer a low-dose, low cost treatment for the amoebic infections that cause human dysentery throughout the world.

21 May 2012

Specific risk factors linked with exacerbation-prone phenotype of severe asthma

A number of specific risk factors are associated with an exacerbation-prone phenotype of severe asthma, according to a new study from researchers in Sweden.

21 May 2012

Quest Diagnostics introduces four new tests panels for CAH

Quest Diagnostics, the world's leading provider of diagnostic testing, information and services, has extended its endocrine diagnostics menu with the introduction of four new tests panels for congenital adrenal hyperplasia (CAH), an endocrine disorder found in newborns, children and women.

From Quest Diagnostics 19 May 2012

Bullying becomes hot topic in the U.S.

Bullying has become a hot topic in the U.S., hitting a cultural nerve as evidenced by the buzz surrounding the recent release of a documentary called "Bully" as well as a book entitled The Bully Society: School Shootings and the Crisis of Bullying in America's Schools.

19 May 2012

American Legion applauds U.S. Army's decision to launch review of mental health cases

The nation's largest wartime veterans organization is applauding the U.S. Army's decision to launch a service-wide review of mental health cases dating back to 2001 to ensure that any soldiers suffering from behavioral health illnesses weren't denied appropriate medical retirement benefits.

19 May 2012

BHI expresses concern over use of long-range acoustic devices

In preparation for the thousands of anti-war activists expected to protest outside the NATO summit in Chicago this week, the city has reportedly ordered $1 million worth of riot-control equipment including a 'sound cannon' that can be used to emit pain-inducing sound waves of up to 150 decibels.

19 May 2012

Cautious optimism over prevalence of PTSD

A decade after the start of the wars in Afghanistan and Iraq, studies have shown that the incidence of post-traumatic stress disorder (PTSD) among troops is surprisingly low, and a Harvard researcher credits the drop, in part, to new efforts by the Army to prevent PTSD, and to ensure those who do develop the disorder receive the best treatment available.

18 May 2012

Urocortin 2 improves cardiac output in Phase II study for acute decompensated heart failure

Neurocrine Biosciences, Inc. today announced efficacy and safety results from a Phase II trial of urocortin 2 in 53 patients with acute decompensated heart failure. The UNICORN study was conducted over approximately a two year period by the Cardioendocrine Research Group from the University of Otago in Christchurch, New Zealand and included patients admitted to Christchurch Hospital with acute decompensated heart failure.

18 May 2012

New equipment guides from DOTmed

DOTmed.com, Inc., the Internet's largest marketplace for new and used medical equipment and parts, has introduced DOTmed New Equipment Guides in print and online.

18 May 2012

Pharmos completes levotofisopam phase 2a trial on hyperuricemia, gout

Pharmos Corporation announced that it has successfully completed a proof-of-concept clinical trial using its compound levotofisopam (S-tofisopam) to treat patients with hyperuricemia and gout.

18 May 2012

Cardiac ischemia plays an important role in adenovector gene transfection in mammalian hearts

Cardium Therapeutics today announced a late-breaking poster presentation at the American Society of Gene & Cell Therapy (ASGCT) 15th Annual Meeting being held May 16-19, 2012 at the Pennsylvania Convention Center in Philadelphia, PA.

17 May 2012

Fitness fanatic dad becomes research pioneer after kidney disease diagnosis

A super-fit father who rowed the distance from the Equator to the North Pole on a rowing machine has told of how his experience of kidney disease led to him becoming the first patient to take part in a groundbreaking research study run in Sheffield and Leeds.

17 May 2012

Lecture discusses how negative emotions fuel cancer formation and metastasis

When it comes to cancer, there are obvious mind-body links. Stress, pessimism and other emotional factors have been proven to play a role, increasing the risk of cancer, metastasis and early mortality. This is a double-whammy for cancer patients, who must overcome anxiety from the moment they are diagnosed. In particular, stress has been shown to depress the immune system, increase inflammation and affect our bodies on the molecular level, even damaging DNA.

17 May 2012

Human memory: how to improve yours

Many of us wish we had better memories: be it so that we can pass our exams; remember what to buy from the supermarket; or even remember what we went upstairs for!

16 May 2012

Scientists identify and prioritize genes associated with schizophrenia

An Indiana University-led research team, along with a group of national and international collaborators, has identified and prioritized a comprehensive group of genes most associated with schizophrenia that together can generate a score indicating whether an individual is at higher or lower risk of developing the disease.

16 May 2012

Reducing off-label antipsychotic use may generate savings with little impact on patient care

Reducing the non-FDA-approved use of antipsychotic drugs may be a way to save money while having little effect on patient care, according to a Penn State College of Medicine study.

16 May 2012

Genetic factor for good memory may increase risk of PTSD in war victims

Experiencing distressing memories of a shocking experience characterizes posttraumatic stress disorder. Scientists from the University of Basel have now discovered that a genetic factor for good memory is also associated with a heightened risk for the development of a posttraumatic stress disorder in war victims.

16 May 2012

Pfizer fails to meet primary endpoint in TORISEL Phase 3 study for advanced RCC

Pfizer Inc announced that the Phase 3 INTORSECT (B1771003) study, evaluating TORISEL(temsirolimus) in patients with advanced renal cell carcinoma (RCC) whose disease had progressed on or after SUTENT (sunitinib malate) therapy, did not meet the primary endpoint of prolonging progression free survival (PFS) when compared to sorafenib.

16 May 2012